Description: This panel discussion session focuses on individual risk classification including regulation that restricts life and health insurers selection criteria.

Description: A recap of the SOA Research Institute's participation in the NAIC Spring 2023 meeting

Description: In light of the bankruptcies of Enron and WorldCom, this panel at the 2003 Valuation Actuary Symposium addresses legislative and regulatory activity, potential implications for the regulation of professions in the United States, and implications for valuation actuaries.

Description: Panelists discuss potential effects on the health insurance system and implications of future developments in genetic technology. From the Record of the Society of Actuaries, Volume 28, No. 3, Session 53.

Description: The big event of 2023 is the launch of multiple Humira biosimilars, which began in January with the arrival of Amgen’s Amjevita on the market. The launch of Amjevita kicks off the process of changing the specialty drug marketplace in the United States. The expectation of the full impact of this big event is very hopeful, but there is still uncertainty several months after its beginning. Humira is the highest-selling drug in the world and has been since 2013 (Figure 1)—except for when COVID-19 projects temporarily surpassed it. The world is eagerly awaiting the launch of multiple biosimilar drugs to compete with Humira and hopefully bring more competitive pricing to the benefit of payers and patients everywhere.

Description: Comparison of domestic and international PFML programs

Description: Retirement isn't a solo endeavor and the prospect of retirement looks starkly different depending on your family, your generation, your income and a host of other socioeconomic factors. The presenters will review the study, 'Financial Perspectives on Aging and Retirement Across the Generations' with an eye towards how these findings impact public policy, plan design for employers and financial planning for individuals and families.

Description: Discusses the recent firing of the Social Security Commissioner and the president's legal authority to do so.

Description: In 2020, the Korean insurance regulator, Financial Services Commission (FSC), introduced a coinsurance structure allowing for full risk transfer—including investment risk, interest rate risk, insurance risk, and policyholder lapse risk—as a permitted practice. Expanding use of coinsurance in the Korean insurance market brings a suite of potential benefits to Korean insurance companies including increased financial flexibility, options to improve policyholder protection and shareholder value through optimization of business strategies. As such, FSC’s initiative and intention to introduce coinsurance opportunities to the market is commendable.

Description: At this session of the SOA 2003 Washington, DC Spring Meeting, the current and past presidents of the NAIC relate various activities of the organization including the areas of consumer protection, insurer regulation and speed to market. Interstate Compact as a method for dealing with variations across states in regulation is discussed.